RxDoctor Payments Data

Lindsey Denny, MD

Dermatology · Katy, TXNPI 1437561867

Payments from drug & device makers

$10,967in general payments, 2019–2025

Across 709 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$2K
  • Lilly USA, LLC$751
  • Mayne Pharma Commercial LLC$724
  • Johnson & Johnson$566
  • E.r. Squibb & Sons, L.L.C.$555
  • plus $4K from 25 others

What the payments were for

  • Food & beverage$10,67597%
  • Education$2923%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,967 in reported general payments places this provider in the 70th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas

Medicare billing

Part B allowed, 2024
$194,826
Medicare patients
470
Services billed
2,917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa16$327,727
Dupixent PenDupilumab38$172,424
Fluorouracil182$11,688
Clobetasol Propionate147$6,299
Betamethasone Dipropionate143$5,601
Ivermectin17$4,913
Triamcinolone Acetonide334$3,151
Doxycycline Monohydrate90$2,401
Tacrolimus14$2,094
Clindamycin Phosphate54$2,091
Fluocinonide41$1,972
Desonide39$1,728
Metronidazole37$1,623
Ketoconazole117$1,391
Tretinoin14$1,206

Paid to pharmacies, not to this prescriber.

Other dermatology in Katy

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →